The DOI matches its Crossref record; 826 of the 826 references it cites were found in a registry or an index.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
Open accessAbstract
In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002, World J Biol Psychiatry 3:171), recommendations for the pharmacological treatment of anxiety disorder, obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) are presented. Since the publication of the first version of this guideline, a substantial number of new randomized controlled studies of anxiolytics have been published. In particular, more relapse prevention studies are now available that show sustained efficacy of anxiolytic drugs. The recommendations, developed by the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-traumatic Stress Disorders, a consensus panel of 30 international experts, are now based on 510 published randomized, placebo- or comparator-controlled clinical studies (RCTs) and 130 open studies and case reports. First-line treatments for these disorders are selective serotonin reuptake inhibitors (SSRIs), serotonin-noradrenaline reuptake inhibitors (SNRIs) and the calcium channel modulator pregabalin. Tricyclic antidepressants (TCAs) are equally effective for some disorders, but many are less well tolerated than the SSRIs/SNRIs. In treatment-resistant cases, benzodiazepines may be used when the patient does not have a history of substance abuse disorders. Potential treatment options for patients unresponsive to standard treatments are described in this overview. Although these guidelines focus on medications, non-pharmacological were also considered. Cognitive behavioural therapy (CBT) and other variants of behaviour therapy have been sufficiently investigated in controlled studies in patients with anxiety disorders, OCD, and PTSD to support them being recommended either alone or in combination with the above medicines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 826
Greist, J. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160039008 · Cited by 243
Friedman, M. J., Marmar, C. R., Baker, D. G., Sikes, C. R., & Farfel, G. M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0508 · Cited by 242
Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., Gee, M., Davy, K., & Machin, A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1153 · Cited by 240
Sertraline for social phobia: a double-blind, placebo-controlled crossover study
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.9.1368 · Cited by 238
Pharmacotherapy for Posttraumatic Stress Disorder Using Phenelzine or Imipramine
KOSTEN, T. R., FRANK, J. B., DAN, E., McDOUGLE, C. J., & GILLER, E. L. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199106000-00011 · Cited by 238
Baer, L. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170058008 · Cited by 237
Cognitive-behavioral treatment of obsessive thoughts: a controlled study
Freeston, M. H., Ladouceur, R., Gagnon, F., Thibodeau, N., Rhéaume, J., Letarte, H., & Bujold, A. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.3.405 · Cited by 234
GELLER, D. A., WAGNER, K. D., EMSLIE, G., MURPHY, T., CARPENTER, D. J., WETHERHOLD, E., PERERA, P., MACHIN, A., & GARDINER, C. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000138356.29099.f1 · Cited by 234
Alonso, P., Pujol, J., Cardoner, N., Benlloch, L., Deus, J., Menchón, J. M., Capdevila, A., & Vallejo, J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1143 · Cited by 234
Vaughan, K., Armstrong, M. S., Gold, R., O'Connor, N., Jenneke, W., & Tarrier, N. (1994) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(94)90036-1 · Cited by 231
Applied relaxation vs. cognitive therapy in the treatment of generalized anxiety disorder
Öst, L.-G., & Breitholtz, E. (2000) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(99)00095-9 · Cited by 229
Leonard, H. L. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340054007 · Cited by 229
Treatment of PTSD: Stress inoculation training with prolonged exposure compared to EMDR
Lee, C., Gavriel, H., Drummond, P., Richards, J., & Greenwald, R. (2002) · Journal of Clinical Psychology · doi:10.1002/jclp.10039 · Cited by 229
Klerman, G. L. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.191 · Cited by 229
Davidson, J., Pearlstein, T., Londborg, P., Brady, K. T., Rothbaum, B., Bell, J., Maddock, R., Hegel, M. T., & Farfel, G. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1974 · Cited by 228
Davidson, J., Baldwin, D., Stein, D. J., Kuper, E., Benattia, I., Ahmed, S., Pedersen, R., & Musgnung, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.10.1158 · Cited by 228
Pande, A. C., Feltner, D. E., Jefferson, J. W., Davidson, J. R. T., Pollack, M., Stein, M. B., Lydiard, R. B., Futterer, R., Robinson, P., Slomkowski, M., et al. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000117423.05703.e7 · Cited by 227
Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study
Van Ameringen, M. A., Lane, R. M., Walker, J. R., Bowen, R. C., Chokka, P. R., Goldner, E. M., Johnston, D. G., Lavallee, Y.-J., Nandy, S., Pecknold, J. C., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.275 · Cited by 223
(1990) · PubMed · Cited by 222
Behavioral treatment of generalized anxiety disorder
Barlow, D. H., Rapee, R. M., & Brown, T. A. (1992) · Behavior Therapy · doi:10.1016/s0005-7894(05)80221-7 · Cited by 221
Bystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220 · cited 1×
“In DBPC studies, the combination of the atypical antipsychotics quetiapine, olanzapine and risperidone with an SSRI was more effective than SSRI monotherapy (Bystritsky et al. 2004; Denys et al. 2004a; Erzegovesi et al. 2005; Hollander et al. 2003b; McDougle et al. 2000; Shapira et al. 2004)(B).”
BackgroundDouble-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder
Ballenger, J. C., Wheadon, D. E., Steiner, M., Bushnell, W., & Gergel, I. P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.36 · Cited by 220
A controlled trial of desipramine in 18 men with posttraumatic stress disorder
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.4.513 · Cited by 218
Blomhoff, S., Haug, T. T., Hellström, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.1.23 · Cited by 218
A meta-analysis of treatments for panic disorder.
Clum, G. A., Clum, G. A., & Surls, R. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.2.317 · Cited by 218
Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M., & Austin, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00013 · Cited by 218
Self-citationCognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study
HAYWARD, C., VARADY, S., ALBANO, A. M., THIENEMANN, M., HENDERSON, L., & SCHATZBERG, A. F. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200006000-00010 · Cited by 217
Fluoxetine Versus Placebo in Posttraumatic Stress Disorder
Martenyi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0305 · Cited by 215
Preliminary study of carbamazepine in post-traumatic stress disorder
Lipper, S., Davidson, J. R. T., Grady, T. A., Edinger, J. D., Hammett, E. B., Mahorney, S. L., & Cavenar, J. O. (1986) · Psychosomatics · doi:10.1016/s0033-3182(86)72590-5 · Cited by 215
Mörtberg, E., Clark, D. M., Sundin, Ö., & Åberg Wistedt, A. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00839.x · Cited by 213 · cited 1×
“In an open study, individual CBT was superior to group CBT and ‘‘treatment as usual’’ with SSRIs (Mortberg et al. 2007).”
BackgroundScheck, M. M., Schaeffer, J. A., & Gillette, C. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024400931106 · Cited by 213
VAN BALKOM, A. J. L. M., BAKKER, A., SPINHOVEN, P., BLAAUW, B. M. J. W., SMEENK, S., & RUESINK, B. (1997) · The Journal of Nervous & Mental Disease · doi:10.1097/00005053-199708000-00006 · Cited by 211
Montgomery, S. A., Tobias, K., Zornberg, G. L., Kasper, S., & Pande, A. C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0511 · Cited by 211
Self-citationRisks Associated With Selective Serotonin Reuptake Inhibitors in Pregnancy
Malm, H., Klaukka, T., & Neuvonen, P. J. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000187302.61812.53 · Cited by 211
How to develop cost-conscious guidelines
Eccles, M., & Mason, J. (2001) · Health Technology Assessment · doi:10.3310/hta5160 · Cited by 211
Inositol treatment of obsessive-compulsive disorder
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1219 · Cited by 209
Combined pharmacological and behavioral treatment for agoraphobia
Telch, M. J., Agras, W. S., Taylor, C. B., Roth, W. T., & Gallen, C. C. (1985) · Behaviour Research and Therapy · doi:10.1016/0005-7967(85)90011-7 · Cited by 209
Treatment of Posttraumatic Stress Disorder: A Review
Shalev, A. Y., Bonne, O., & Eth, S. (1996) · Psychosomatic Medicine · doi:10.1097/00006842-199603000-00012 · Cited by 207
Furmark, T., Appel, L., Michelgård, Å., Wahlstedt, K., Åhs, F., Zancan, S., Jacobsson, E., Flyckt, K., Grohp, M., Bergström, M., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.029 · Cited by 206
Psychosocial treatment of posttraumatic stress disorder.
Foa, E. B. (2000) · PubMed · Cited by 205
Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework
Marks, I. M. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790020047004 · Cited by 204
Power, K., McGoldrick, T., Brown, K., Buchanan, R., Sharp, D., Swanson, V., & Karatzias, A. (2002) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.341 · Cited by 203
Bandelow, B., Baldwin, D. S., Dolberg, O. T., Andersen, H. F., & Stein, D. J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0914 · Cited by 203
Self-citationA Controlled Study of Fluvoxamine and Exposure in Obsessive-Compulsive Disorder
COTTRAUX, J., MOLLARD, E., BOUVARD, M., MARKS, I., SLUYS, M., NURY, A. M., DOUGE, R., & CIALDELLA, P. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199001000-00002 · Cited by 203
Treatment of generalized anxiety disorder in older adults.
Wetherell, J. L., Gatz, M., & Craske, M. G. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.71.1.31 · Cited by 201
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder
Storch, E. A., Merlo, L. J., Bengtson, M., Murphy, T. K., Lewis, M. H., Yang, M. C., Jacob, M. L., Larson, M., Hirsh, A., Fernandez, M., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32819f8480 · Cited by 200 · cited 1×
“However, the results of DBPC studies in OCD were disappointing (Kushner et al. 2007; Storch et al. 2007; Wilhelm et al. 2008)(E).”
King, R. A., Leonard, H., & March, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199810001-00003 · Cited by 200
Berlant, J., & van Kammen, D. P. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0104 · Cited by 200
Anderson, D., & Ahmed, A. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.98.5.1104 · Cited by 200
Lafleur, D. L., Pittenger, C., Kelmendi, B., Gardner, T., Wasylink, S., Malison, R. T., Sanacora, G., Krystal, J. H., & Coric, V. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0246-6 · Cited by 199
Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study
Rickels, K., Zaninelli, R., McCafferty, J., Bellew, K., Iyengar, M., & Sheehan, D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.749 · Cited by 198
Hollander, E., Rossi, N. B., Sood, E., & Pallanti, S. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003730 · Cited by 197 · cited 2×
“In DBPC studies, the combination of the atypical antipsychotics quetiapine, olanzapine and risperidone with an SSRI was more effective than SSRI monotherapy (Bystritsky et al. 2004; Denys et al. 2004a; Erzegovesi et al. 2005; Hollander et al. 2003b; McDougle et al. 2000; Shapira et al. 2004)(B).”
BackgroundSelf-citationGrant, P., Lougee, L., Hirschtritt, M., & Swedo, S. E. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0021 · Cited by 197
Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial
Davidson, J. R. T., Weisler, R. H., Butterfield, M. I., Casat, C. D., Connor, K. M., Barnett, S., & van Meter, S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01411-7 · Cited by 197
Non-inferiority trials are unethical because they disregard patients' interests
Garattini, S., & Bertele', V. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61604-3 · Cited by 197
Den Boer, J. A., & Westenberg, H. G. M. (1990) · Psychopharmacology · doi:10.1007/bf02245749 · Cited by 197
Controlled study of treatment of PTSD using EMDR in an HMO setting.
Marcus, S. V., Marquis, P., & Sakai, C. (1997) · Psychotherapy: Theory, Research, Practice, Training · doi:10.1037/h0087791 · Cited by 197
Clonidine in Cambodian Patients with Posttraumatic Stress Disorder
KINZIE, J. D., & LEUNG, P. (1989) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198909000-00005 · Cited by 196
Paroxetine efficacy in the treatment of generalized anxiety disorder
Rocca, P., Fonzo, V., Scotta, M., Zanalda, E., & Ravizza, L. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09660.x · Cited by 194
Haby, M. M., Donnelly, M., Corry, J., & Vos, T. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01736.x · Cited by 193
Durham, R. C., Murphy, T., Allan, T., Richard, K., Treliving, L. R., & Fenton, G. W. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.165.3.315 · Cited by 192
An open trial of fluoxetine in the treatment of panic attacks.
Gorman, J. M., Liebowitz, M. R., Fyer, A. J., Goetz, D. M., Campeas, R. B., Fyer, M. R., Davies, S. O., & Klein, D. F. (1987) · PubMed · Cited by 192
Long-term Therapeutic Use of Benzodiazepines: II. Effects of Gradual Taper
Schweizer, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220024003 · Cited by 191
Lattimore, K. A., Donn, S. M., Kaciroti, N., Kemper, A. R., Neal, C. R., & Vazquez, D. M. (2005) · Journal of Perinatology · doi:10.1038/sj.jp.7211352 · Cited by 189
Lippitz, B. E., Mindus, P., Meyerson, B. A., Kihlström, L., & Lindquist, C. (1999) · Neurosurgery · doi:10.1097/00006123-199903000-00005 · Cited by 189
Social phobia: A comparison of behavior therapy and atenolol.
Turner, S. M., Beidel, D. C., & Jacob, R. G. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.2.350 · Cited by 189
Fluoxetine in Children and Adolescents With OCD: A Placebo-Controlled Trial
LIEBOWITZ, M. R., TURNER, S. M., PIACENTINI, J., BEIDEL, D. C., CLARVIT, S. R., DAVIES, S. O., GRAAE, F., JAFFER, M., LIN, S.-H., SALLEE, F. R., et al. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200212000-00014 · Cited by 188
Rynn, M. A., Riddle, M. A., Yeung, P. P., & Kunz, N. R. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.290 · Cited by 188
A crossover study of focused cognitive therapy for panic disorder
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.6.778 · Cited by 187
Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Farrell, C., Wagner, K. D., Emslie, G., & Carpenter, D. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322126313 · Cited by 187
Montgomery, S. A., Kasper, S., Stein, D. J., Hedegaard, K. B., & Lemming, O. M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200103000-00002 · Cited by 187
Self-citationFeighner, J. P., Merideth, C., & Hendrickson, G. A. (1982) · PubMed · Cited by 187
Boyer, W. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199503000-00006 · Cited by 184
Genetics of Affective and Anxiety Disorders
Leonardo, E. D., & Hen, R. (2006) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190118 · Cited by 184
Diazepam and Propranolol in Panic Disorder and Agoraphobia
Noyes, R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790140077009 · Cited by 184
A comparison of bibliotherapy and group therapy in the treatment of panic disorder.
Lidren, D. M., Watkins, P. L., Gould, R. A., & Clum, G. A. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.62.4.865 · Cited by 184
Anxiety as a Developmental Disorder
Leonardo, E. D., & Hen, R. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301569 · Cited by 183
Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
Nordeng, H., Lindemann, R., Perminov, K. V., & Reikvam1, Å. (2001) · Acta Paediatrica · doi:10.1080/080352501300067596 · Cited by 181
Anxiety Characteristics Independently and Prospectively Predict Myocardial Infarction in Men
Shen, B., Avivi, Y. E., Todaro, J. F., Spiro, A., Laurenceau, J., Ward, K. D., & NIAURA, R. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.033 · Cited by 180
Tolin, D. F., Maltby, N., Diefenbach, G. J., Hannan, S. E., & Worhunsky, P. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0708 · Cited by 180
A randomized controlled trial of individual psychological debriefing for victims of violent crime
ROSE, S., BREWIN, C. R., ANDREWS, B., & KIRK, M. (1999) · Psychological Medicine · doi:10.1017/s0033291799008624 · Cited by 179
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.1084 · Cited by 177
Mohlman, J., Gorenstein, E. E., Kleber, M. S., de Jesus, M., Gorman, J. M., & Papp, L. A. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200301000-00005 · Cited by 177
An effect-size analysis of pharmacologic treatments for generalized anxiety disorder
Hidalgo, R. B., Tupler, L. A., & Davidson, J. R. T. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107076996 · Cited by 177
SIMEON, J. G., FERGUSON, H. B., KNOTT, V., ROBERTS, N., GAUTHIER, B., DUBOIS, C., & WIGGINS, D. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00006 · Cited by 177
Allgulander, C., Hackett, D., & Salinas, E. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.1.15 · Cited by 175
ECT, Research, and Professional Ambivalence
Salzman, C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.1 · Cited by 175
Davidson, J. R. T., Bose, A., Korotzer, A., & Zheng, H. (2004) · Depression and Anxiety · doi:10.1002/da.10146 · Cited by 175
An Open Trial of Fluoxetine in the Treatment of Panic Attacks
GORMAN, J. M., LIEBOWITZ, M. R., FYER, A. J., GOETZ, D., CAMPEAS, R. B., FYER, M. R., DAVIES, S. O., & KLEIN, D. F. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198710000-00007 · Cited by 175
A controlled trial of phenelzine in posttraumatic stress disorder
Shestatzky, M., Greenberg, D., & Lerer, B. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90057-1 · Cited by 173
Montgomery, S. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90266-o · Cited by 172
PRICE, J. S., WALLER, P. C., WOOD, S. M., & MACKAY, A. V. P. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.00498.x · Cited by 171
Panic, suffocation false alarms, separation anxiety and endogenous opioids
Preter, M., & Klein, D. F. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.029 · Cited by 170
Valproate in combat-related posttraumatic stress disorder.
Fesler, F. A. (1991) · PubMed · Cited by 170
Does Brief Dynamic Psychotherapy Reduce the Relapse Rate of Panic Disorder?
Wiborg, I. M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080041008 · Cited by 169
Stein, D. J., Bouwer, C., Hawkridge, S., & Emsley, R. A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0306 · Cited by 169
Sachdev, P. S., Loo, C. K. A., Mitchell, P. B., McFarquhar, T. F., & Malhi, G. S. (2007) · Psychological Medicine · doi:10.1017/s0033291707001092 · Cited by 169
Pohl, R. B., Feltner, D. E., Fieve, R. R., & Pande, A. C. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155820.74832.b0 · Cited by 168
Cognitive Behavioral Treatment Compared With Nonprescriptive Treatment of Panic Disorder
Shear, M. K., Pilkonis, P. A., Cloitre, M., & Leon, A. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050055006 · Cited by 168
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150621 · Cited by 167
Self-citationBandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D., & Rüther, E. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970601110273 · Cited by 166 · cited 3×
“According to a meta-analysis of studies with both a psychological and a drug treatment arm, there is only preliminary support for combined treatment for social anxiety disorder (Bandelow et al. 2007a).”
BackgroundMethodInfluentialSelf-citationAugmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder
ROTHBAUM, B. O., Cahill, S. P., Foa, E. B., Davidson, J. R. T., Compton, J., Connor, K. M., Astin, M. C., & Hahn, C. (2006) · Journal of Traumatic Stress · doi:10.1002/jts.20170 · Cited by 166
Marshall, R. D., Schneier, F. R., Fallon, B. A., Knight, C., Abbate, L. A., Goetz, D. M., Campeas, R. B., & Liebowitz, M. R. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00003 · Cited by 166
Placebo-controlled trial of fluoxetine and phenelzine for obsessive- compulsive disorder
Jenike, M. A., Baer, L., Minichiello, W. E., Rauch, S. L., & Buttolph, M. L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1261 · Cited by 164
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1209 · Cited by 164
Borkovec, T. D., Mathews, A., Chambers, A., Ebrahimi, S., Lytle, R. A., & Nelson, R. (1987) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.55.6.883 · Cited by 164
Lader, M., Stender, K., Bürger, V., & Nil, R. (2004) · Depression and Anxiety · doi:10.1002/da.20014 · Cited by 163
Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review
Furukawa, T. A., Watanabe, N., & Churchill, R. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.4.305 · Cited by 163
Low-Dose Risperidone as Adjunctive Therapy for Irritable Aggression in Posttraumatic Stress Disorder
Monnelly, E. P., Ciraulo, D. A., Knapp, C., & Keane, T. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00012 · Cited by 163
Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
Goodman, W., Rasmussen, S., Price, L., Mazure, L., Heninger, G., & Charney, D. (1991) · Verhaltenstherapie · doi:10.1159/000257973 · Cited by 163
Jensen, J. A. (1994) · Behavior Therapy · doi:10.1016/s0005-7894(05)80290-4 · Cited by 163
Hamner, M. B., Faldowski, R. A., Ulmer, H. G., Frueh, B. C., Huber, M. G., & Arana, G. W. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200301000-00001 · Cited by 162
Deahl, M., Srinivasan, M., Jones, N., Thomas, J., Neblett, C., & Jolly, A. (2000) · British Journal of Medical Psychology · doi:10.1348/000711200160318 · Cited by 162
Otto, M. W., Tuby, K. S., Gould, R. A., McLean, R. Y. S., & Pollack, M. H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.1989 · Cited by 162
Antidepressants plus benzodiazepines for major depression
Furukawa, T. A., Streiner, D., Young, L. T., & Kinoshita, Y. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001026 · Cited by 161
McDougle, C. J., Price, L. H., Goodman, W. K., Charney, D. S., & Heninger, G. R. (1991) · PubMed · Cited by 161
Taylor, F., & Raskind, M. A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00013 · Cited by 161
Lack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans
Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Kudler, H. S., & Davidson, J. R. T. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009076231175 · Cited by 161
Post-treatment effects of exposure therapy and clomipramine in obsessive–compulsive disorder
Simpson, H. B., Liebowitz, M. R., Foa, E. B., Kozak, M. J., Schmidt, A. B., Rowan, V., Petkova, E., Kjernisted, K., Huppert, J. D., Franklin, M. E., et al. (2004) · Depression and Anxiety · doi:10.1002/da.20003 · Cited by 161
The use of bibliotherapy in the treatment of panic: A preliminary investigation
Gould, R. A., Clum, G. A., & Shapiro, D. (1993) · Behavior Therapy · doi:10.1016/s0005-7894(05)80266-7 · Cited by 160 · cited 1×
“1993, 1995; Williams and Falbo 1996), with one exception (Gould et al. 1993).”
BackgroundVenlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder
Liebowitz, M. R., Gelenberg, A. J., & Munjack, D. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.190 · Cited by 160
Early Coadministration of Clonazepam With Sertraline for Panic Disorder
Goddard, A. W., Brouette, T., Almai, A., Jetty, P. V., Woods, S. W., & Charney, D. S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.7.681 · Cited by 159
Cognitive-behavioral group therapy in obsessive–compulsive disorder: a randomized clinical trial
Volpato Cordioli, A., Heldt, E., Braga Bochi, D., Margis, R., Basso de Sousa, M., Fonseca Tonello, J., Gus Manfro, G., & Kapczinski, F. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000070785 · Cited by 158
Pollack, M. H., Worthington, J. J., Manfro, G. G., Otto, M. W., & Zucker, B. G. (1997) · PubMed · Cited by 158
Katz, I. R., Reynolds, C. F., Alexopoulos, G. S., & Hackett, D. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50003.x · Cited by 158
MAVISSAKALIAN, M. R., & Michelson, L. K. (1986) · PubMed · Cited by 157
Davidson, J., Rothbaum, B. O., Tucker, P., Asnis, G., Benattia, I., & Musgnung, J. J. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222514.71390.c1 · Cited by 157
Impact of cognitive)ehavioral treatment on quality of life in panic disorder patients.
Telch, M. J., Schmidt, N. B., Jaimez, T. L., Jacquin, K. M., & al, E. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.63.5.823 · Cited by 157
A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder
March, J. S., Entusah, A. R., Rynn, M., Albano, A. M., & Tourian, K. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.025 · Cited by 156 · cited 1×
“2004) and children and adolescents (March et al. 2007).”
Hollander, E., Allen, A., Steiner, M., Wheadon, D. E., Oakes, R., Burnham, D. B., & Paroxetine OCD Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0919 · Cited by 156
Self-citationHoehn‐Saric, R., McLeod, D. R., & Zimmerli, W. D. (1988) · PubMed · Cited by 156
Gabapentin in PTSD: A Retrospective, Clinical Series of Adjunctive Therapy1
Hamner, M. B., Brodrick, P. S., & Labbate, L. A. (2001) · Annals of Clinical Psychiatry · doi:10.1023/a:1012281424057 · Cited by 155
Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney, D. S., Woods, S. W., Goodman, W. K., Rifkin, B. G., Kinch, M., Aiken, B. E., Quadrino, L. M., & Heninger, G. R. (1986) · PubMed · Cited by 155
How Psychiatrists Can Build New Therapies for Impotence
Stahl, S. M. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0201 · Cited by 154
Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.
Saxena, S., Wang, D., Bystritsky, A., & Baxter, L. R. (1996) · PubMed · Cited by 154
Raskind, M. A., Dobie, D. J., Kanter, E. D., Petrie, E. C., Thompson, C. E., & Peskind, E. R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0208 · Cited by 154
Shapira, N. A., Ward, H. E., MANDOKI, M. W., Murphy, T. K., Yang, M. C. K., Blier, P., & Goodman, W. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.010 · Cited by 154
A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder
Lecrubier, Y., Bakker, A., Dunbar, G., Judge, R., & The Collaborative Paroxetine Panic Study Investigators (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00388.x · Cited by 153
The effect of Citalopram in panic disorder
Wade, A. G., Lepola, U. M., Koponen, H., Pedersen, V., & Pedersen, T. (1997) · The British Journal of Psychiatry · doi:10.1192/bjp.170.6.549 · Cited by 153
Cognitive therapy versus applied relaxation as treatment of generalized anxiety disorder
Arntz, A. (2003) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(02)00045-1 · Cited by 152
Rynn, M. A., Russell, J., Erickson, J., Detke, M. J., Ball, S. G., Dinkel, J., Rickels, K., & Raskin, J. (2007) · Depression and Anxiety · doi:10.1002/da.20271 · Cited by 152
Exposure therapy and sertraline in social phobia: 1-year follow-up of a randomised controlled trial
Haug, T. T., Blomhoff, S., Hellstrøm, K., Holme, I., Humble, M., Madsbu, H. P., & Wold, J. E. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.4.312 · Cited by 151 · cited 1×
“Improvement was also shown in the placebo group, so that the effects were probably due to spontaneous remission (Bandelow 2004; Bandelow and Haug 2004; Haug et al. 2003).”
BackgroundA Double Blind Comparison of Venlafaxine and Paroxetine in Obsessive-Compulsive Disorder
Denys, D., van der Wee, N., van Megen, H. J. G. M., & Westenberg, H. G. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095342.32154.54 · Cited by 151
WCA Recommendations for the Long-Term Treatment of Obsessive-Compulsive Disorder in Adults
Greist, J. H., Bandelow, B., Hollander, E., Marazziti, D., Montgomery, S., Nutt, D., Okasha, A., Swinson, R. P., & Zohar, J. (2003) · CNS Spectrums · doi:10.1017/s1092852900006908 · Cited by 151
Self-citationIs Buspirone Effective for Panic Disorder?
Sheehan, D. V., Raj, A. B., Sheehan, K. H., & SOTO, S. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199002000-00002 · Cited by 151
Efficacy of Sertraline in the Long-Term Treatment of Obsessive-Compulsive Disorder
Koran, L. M., Hackett, E., Rubin, A., Wolkow, R., & Robinson, D. G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.88 · Cited by 151
Noyes, R., Moroz, G., Davidson, J. R. T., Liebowitz, M. R., Davidson, A. B., Siegel, J., Bell, J., Cain, J. W., Curlik, S. M., Kent, T. A., et al. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00002 · Cited by 150
Woelk, H., Arnoldt, K., Kieser, M., & Hoerr, R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.004 · Cited by 149
Current treatments of the anxiety disorders in adults
Ballenger, J. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00220-6 · Cited by 149
Efficacy of Sertraline in a 12-Week Trial for Generalized Anxiety Disorder
Allgulander, C., Dahl, A. A., Austin, C., Morris, P., Søgaard, J., Fayyad, R. S., Kutcher, S., & Clary, C. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1642 · Cited by 149
Hoehn‐Saric, R., Ninan, P. T., Black, D. W., Stahl, S. M., Greist, J. H., Lydiard, B., McElroy, S. L., Zajecka, J., Chapman, D. S., Clary, C. M., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.76 · Cited by 148
Hamner, M. B., Deitsch, S. E., Brodrick, P. S., Ulmer, H. G., & Lorberbaum, J. P. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00003 · Cited by 147
Möller, H., Volz, H., Reimann, I. W., & Stoll, K.-D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00011 · Cited by 147
Self-citationPlacebo-controlled trial of moclobemide in social phobia
Schneier, F. R., Goetz, D. M., Campeas, R. B., Marshall, R. D., Fallon, B., & Liebowitz, M. R. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.172.1.70 · Cited by 147
Pollack, M. H., Simon, N. M., Zalta, A. K., Worthington, J. J., Hoge, E. A., Mick, E. O., Kinrys, G., & Oppenheimer, J. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.005 · Cited by 146
Atmaca, M., Kuloğlu, M. M., Tezcan, E., & Geçici, Ö. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00004 · Cited by 146
Prazosin Reduces Nightmares in Combat Veterans With Posttraumatic Stress Disorder
Raskind, M. A., Thompson, C. E., Petrie, E. C., Dobie, D. J., Rein, R. J., Hoff, D. J., McFall, M., & Peskind, E. R. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0705 · Cited by 146
Bankier, B., Januzzi, J. L., & Littman, A. B. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000138126.90551.62 · Cited by 146
Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder.
Mitchell, J. E., Specker, S. M., & de Zwaan, M. (1991) · PubMed · Cited by 145
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.683 · Cited by 144
Patient perspectives on once-weekly fluoxetine.
Judge, R. (2001) · PubMed · Cited by 144
A Double-Blind Switch Study of Paroxetine and Venlafaxine in Obsessive-Compulsive Disorder
Denys, D. A. J. P., van Megen, H. J. G. M., van der Wee, N. J. A., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0106 · Cited by 144
Community Survey of Bipolar Disorder in Canada: Lifetime Prevalence and Illness Characteristics
Schaffer, A., Cairney, J., Cheung, A., Veldhuizen, S., & Levitt, A. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100104 · Cited by 143
Sertraline in the Treatment of Panic Disorder
Pollack, M. H., Otto, M. W., Worthington, J. J., Manfro, G. G., & Wolkow, R. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.11.1010 · Cited by 143
Londborg, P. D., Wolkow, R., Smith, W. T., DuBoff, E., England, D., Ferguson, J. M., Rosenthal, M. H., & Weise, C. C. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.1.54 · Cited by 143
Hypnotic Medication in the Aftermath of Trauma
Mellman, T. A., Bustamante, V., David, D., & Fins, A. I. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1214h · Cited by 142
Efficacy of Cognitive Behaviour Therapy in Generalized Anxiety Disorders
Linden, M., Zubraegel, D., Baer, T., Franke, U., & Schlattmann, P. (2005) · Psychotherapy and Psychosomatics · doi:10.1159/000082025 · Cited by 142
Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
Llorca, P., Spadone, C., Sol, O., Danniau, A., Bougerol, T., Corruble, E., Faruch, M., Macher, J.-P., Sermet, É., & Servant, D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1112 · Cited by 141
Stahl, S. M., Gergel, I. P., & Li, D. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1107 · Cited by 141
Kasper, S. F., Stein, D. J., Loft, H., & Nil, R. (2005) · The British Journal of Psychiatry · doi:10.1192/bjp.186.3.222 · Cited by 141
Self-citationVersiani, M., Cassano, G. B., Perugi, G., Benedetti, A., Mastalli, L., Nardi, A. E., & Savino, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0107 · Cited by 140
Long‐term evaluation of paroxetine, clomipramine and placebo in panic disorder
Lecrubier, Y., Judge, R., & The Collaborative Paroxetine Panic Study Investigators (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb00389.x · Cited by 139
Prazosin Reduces Trauma-Related Nightmares in Older Men with Chronic Posttraumatic Stress Disorder
Peskind, E. R., Bonner, L. T., Hoff, D. J., & Raskind, M. A. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703256050 · Cited by 139
Erzegovesi, S., Guglielmo, E., Siliprandi, F., & Bellodi, L. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.04.004 · Cited by 138
Stein, D. J., Andersen, E. W., Tonnoir, B., & Fineberg, N. A. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x178838 · Cited by 137
Chouinard, G., Goodman, W. K., Greist, J. H., Jenike, M. A., Rasmussen, S., White, K., Hackett, E., Gaffney, M., & Bick, P. A. (1990) · PubMed · Cited by 136
Sertraline Treatment of Posttraumatic Stress Disorder
Londborg, P. D., Hegel, M. T., Goldstein, S., Goldstein, D., Himmelhoch, J. M., Maddock, R. J., Patterson, W. M., Rausch, J. L., & Farfel, G. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0503 · Cited by 136
Skapinakis, P., Papatheodorou, T., & Mavreas, V. G. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.07.002 · Cited by 136
Long-term efficacy of pregabalin in generalized anxiety disorder
Feltner, D. E., Wïttchen, H., Kavoussi, R. J., Brock, J., Baldinetti, F., & Pande, A. C. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f0f0d7 · Cited by 136
LADER, M. H., & Scotto, J. (1998) · Psychopharmacology · doi:10.1007/s002130050731 · Cited by 135
The Use of Aripiprazole in Obsessive-Compulsive Disorder
Connor, K. M., Payne, V., Gadde, K. M., Zhang, W., & Davidson, J. R. T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0107 · Cited by 135
Lenze, E. J., Mulsant, B. H., Shear, M. K., Dew, M. A., Miller, M. D., Pollock, B. G., Houck, P., Tracey, B., & Reynolds, C. F. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.146 · Cited by 135
Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder
Martényi, F., Brown, E. B., Zhang, H., Koke, S. C., & Prakash, A. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.4.315 · Cited by 134
Oberlander, T. F., Warburton, W. P., Misri, S. K., Aghajanian, J., & Hertzman, C. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037101 · Cited by 134
Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial
Pohl, R. B., Wolkow, R., & Clary, C. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1189 · Cited by 134
A Controlled Trial of Lithium Augmentation in Fluvoxamine-Refractory Obsessive-Compulsive Disorder
McDougle, C. J., Price, L. H., Goodman, W. K., Charney, D. S., & Heninger, G. R. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199106000-00005 · Cited by 134
Carey, P. D., Vythilingum, B., Seedat, S., Muller, J. E., van Ameringen, M., & Stein, D. J. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-5 · Cited by 133
Pollack, M. H., Simon, N. M., Worthington, J. J., Doyle, A. L., Peters, P., Toshkov, F., & Otto, M. W. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173009 · Cited by 133
Greist, J. H., Jefferson, J. W., Kobak, K. A., Chouinard, G., DuBoff, E., Halaris, A., Kim, S. W., Koran, L. M., Liebowtiz, M. R., Lydiard, B., et al. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199506000-00001 · Cited by 133
Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder
Koran, L. M., Aboujaoude, E. N., Bullock, K. D., Franz, B., Gamel, N. N., & Elliott, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0312 · Cited by 132
Efficacy of olanzapine in social anxiety disorder: a pilot study
Barnett, S. D., Kramer, M. L., Casat, C. D., Connor, K. M., & Davidson, J. R. T. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600412 · Cited by 131
Prevention of relapse in generalized anxiety disorder by escitalopram treatment
Allgulander, C., Florea, I., & Huusom, A. K. T. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005973 · Cited by 131
Can Posttraumatic Stress Disorder Be Prevented with Glucocorticoids?
SCHELLING, G., ROOZENDAAL, B., & de QUERVAIN, D. J. ‐. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.013 · Cited by 130
van der Linden, G. J., Stein, D. J., & van Balkom, A. J. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200008002-00004 · Cited by 130
Bogetto, F., Bellino, S., Vaschetto, P., & Ziero, S. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00203-1 · Cited by 130
Cardiovascular Changes Associated With Venlafaxine in the Treatment of Late-Life Depression
Johnson, E. M., Whyte, E. M., Mulsant, B. H., Pollock, B. G., Weber, E., Begley, A. E., & Reynolds, C. F. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000204328.50105.b3 · Cited by 130
Clomipramine, Clonazepam, and Clonidine Treatment of Obsessive-Compulsive Disorder
HEWLETT, W. A., VINOGRADOV, S., & AGRAS, W. S. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199212000-00008 · Cited by 129
Mindus, P., Rasmussen, S. A., & Lindquist, C. (1994) · Journal of Neuropsychiatry · doi:10.1176/jnp.6.4.467 · Cited by 129
Efficacy and Tolerability of Paroxetine for the Long-Term Treatment of Generalized Anxiety Disorder
Stocchi, F., Nordera, G., Jokinen, R., Lepola, U. M., Hewett, K., Bryson, H., Iyengar, M. K., & Paroxetine Generalized Anxiety Disorder Study Team (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0305 · Cited by 128
Anterior cingulotomy for refractory obsessive–compulsive disorder
Kim, C. ‐., Chang, J. W., Koo, M. ‐., Kim, J. W., Suh, H. S., Park, I. H., & Lee, H. S. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00087.x · Cited by 127 · cited 1×
“2003; Rück, 2006; Skoog and Skoog 1999), cingulotomy (Baer et al. 1995; Dougherty et al. 2002; Jenike et al. 1991a; Kim et al. 2003; Richter et al. 2004), limbic leucotomy (Cumming et al.”
Background
Research works printed but not linked: 116
- Altshuler LL, 2001, Postgrad Med, 1
- Amore M, 1999, Hum Psychopharmacol Clin Exp, 14, 435, 10.1002/(SICI)1099-1077(199908)14:6<435::AID-HUP109>3.0.CO;2-B · doi:10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b
- Bakish D, 1996, Psychopharmacol Bull, 32, 135
- Ballenger JC, 2001, J Clin Psychiatry, 62, 53
- Bandelow B, 2004, Br J Psychiatry, 184, 271, 10.1192/bjp.184.3.271 · DOI
- Bandelow B, 2002, Eur Neuropsychopharmacol, 12, S364, 10.1016/S0924-977X(02)80585-5 · doi:10.1016/s0924-977x(02)80585-5
- Bradwejn J, 1993, Can J Psychiatry, 38, S109
- Braun P, 1990, J Clin Psychiatry, 51, 236
- Bystritsky A, 2008, Psychopharmacol Bull, 41, 46
- 10.3109/10401239909147053 · doi:10.3109/10401239909147053
- Chao IL, 2004, Pharmacopsychiatry, 37, 239, 10.1055/s-2004-832600 · DOI
- Charney DS, 1989, J Clin Psychiatry, 50, 418
- Charney DS, 1986, J Clin Psychiatry, 47, 580
- Chouinard G, 1990, Psychopharmacol Bull, 26, 279
- 10.3109/10401230490281609 · doi:10.3109/10401230490281609
- Davis LL, 2008, Psychopharmacol Bull, 41, 8
- DeVeaugh-Geiss J, 1989, Psychopharmacol Bull, 25, 36
- Dieleman GC, 2008, Tijdschr Psychiatr, 50, 43
- Dunner DL, 1986, J Clin Psychiatry, 47, 458
- Eriksson T, 2007, Int Clin Psychopharmacol, 22, 57
- Feighner JP, 1987, J Clin Psychiatry (Suppl), 48, 3
- Feighner JP, 1982, J Clin Psychiatry, 43, 103
- Feltner DE, 2003, J Clin Psychopharmacol, 23, 240
- Ferreri M, 1994, Encéphale, 20, 785
- 10.1037/0022-006X.65.6.1026 · doi:10.1037/0022-006x.65.6.1026
- Fesler FA, 1991, J Clin Psychiatry, 52, 361
- Foa EB, 2000, J Clin Psychiatry, 61, 43
- Frommberger U, 2004, Fortschr Neurol Psychiatr, 72, 411, 10.1055/s-2004-818455 · doi:10.1055/s-2004-818455
- Gelpin E, 1996, J Clin Psychiatry, 57, 390
- Gruber RP, 1971, Dis Nerv Syst, 32, 180
- Hamner MB, 2001, Ann Clin Psychiatry, 13, 141, 10.3109/10401230109148960 · DOI
- 10.3109/10401230009147096 · DOI · Paper page
- Hoehn-Saric R, 1988, J Clin Psychiatry, 49, 293
- Hoffart A, 1993, J Clin Psychiatry, 54, 481
- 10.1037/0022-006X.72.3.393 · DOI
- Hofmann SG, 2008, J Clin Psychiatry, e1
- Husain MM, 1993, Am J Psychiatry, 150, 1899
- Jenike MA, 1991, J Clin Psychiatry, 52, 13
- Khanna S, 1988, Convuls Ther, 4, 314
- Klerman GL, 199, Social Morbidity Health Care Utilization J, 265, 742
- Kocabasoglu N, 2004, Eur Neuropsychopharmacol, 14, S304, 10.1016/S0924-977X(04)80382-1 · doi:10.1016/s0924-977x(04)80382-1
- Koran LM, 2007, Am J Psychiatry, 164, 5
- Lee C, 2002, J Clin Psychol Psychother, 58, 1071
- Lenox-Smith AJ, 2003, Br J Gen Pract, 53, 772
- Li D, 2001, J Psychiatry Neurosci, 26, 190
- Lidren DM, 1994, J Consult Clin Psychol, 62, 865, 10.1037/0022-006X.62.4.865 · DOI · Paper page
- Liebowitz MR, 1988, J Clin Psychiatry, 49, 252
- 10.1002/(SICI)1520-6394(1999)10:3%3C89::AID-DA1%3E3.0.CO;2-5 · doi:10.1002/(sici)1520-6394(1999)10:3<89::aid-da1>3.0.co;2-5
- Livingston MG, 1994, Br J Hosp Med, 51, 281
- Lopes AC, 2008, Biol Psychiaty, 63, 131s, 10.1016/j.biopsych.2007.11.007 · doi:10.1016/j.biopsych.2007.11.007
- López-Ibor JJ, 1975, Neurological treatment in psychiatry, pain and epilepsy, 151
- Lum M, 1990, Biol Psychiatry :A, 27, 164
- Maletzky B, 1994, Convuls Ther, 10, 34
- Marazziti D, 1999, Am J Psychiatry, 156, 1834, 10.1176/ajp.156.11.1834-a · doi:10.1176/ajp.156.11.1834-a
- Marmar CR, 1996, J Clin Psychiatry, 57, 66
- Mavissakalian M, 1983, Psychopharmacol Bull, 19, 116
- Mavissakalian M, 1986, J Clin Psychol, 47, 117
- Meibach RC, 1987, J Clin Psychiatry, 48, 355
- Misri S, 2000, Can Family Phys, 46, 626
- Mohlman J, 2003, Am J Geriatr Psychiatry, 11, 24
- Montoya A, 2002, Neurosurgery, 50, 1043
- Munjack DJ, 1989, J Clin Psychopharmacol, 9, 22
- Munjack DJ, 1990, J Clin Psychiatry, 51, 35
- Nelson J, 1999, Can Soc Clin Pharmacol, 6, 69
- Neylan TC, 2006, Am J Psychiatry, 163, 2186, 10.1176/ajp.2006.163.12.2186 · doi:10.1176/ajp.2006.163.12.2186
- Nicolini H, 2008, Psychol Med, 1
- NIMH 1976. National Institute of Mental Health. 028 CGI. Clinical Global Impressions. In: Guy E, ECDEU Assessment manual for psychopharmacology. Revised edition. Rockville, MD: NIMH. p 217–222.
- Noyes R, 1996, J Clin Psychiatry, 57, 349
- Nutt DJ, 1998, J Clin Psychiatry, 59, 4
- Ontiveros A, 1992, J Psychiatry Neurosci, 17, 78
- Pastrana Jiménez JI, 2007, Actas Esp Psiquiatr, 35, 351
- Pigott TA, 1992, J Clin Psychopharmacol, 12, 11
- Pollack MH, 2003, Psychopharmacol Bull, 37, 53
- Pollack MH, 1994, J Clin Psychiatry, 55, 200
- Pollack MH, 1996, Psychopharmacol Bull, 32, 667
- Pollack MH, 1997, J Clin Psychiatry, 58, 19
- Pols H, 1993, Acta Psychiatr Belg, 93, 169
- Power KG, 1990, Br J Gen Pract, 40, 289
- Prasko J, 2006, Neuroendocrinol Lett, 27, 473
- Prasko J, 2006, Neuroendocrinol Lett, 27, 327
- 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
- Ravizza L, 1996, Psychopharmacol Bull, 32, 677
- 10.1037/0022-006X.70.4.86 · doi:10.1037/0022-006x.70.4.86
- Rickels K, 1982, J Clin Psychiatry, 43, 81
- Riddle MA, 1996, Psychopharmacol Bull, 32, 399
- Rizley R, 1986, Psychopharmacol Bull, 22, 167
- Rothbaum B, 1997, Bull Menninger Clinic, 61, 317
- Rothbaum BO, 2008, J Clin Psychiatry, e1
- Rück C, 2006, Capsulotomy in anxiety disorders [thesis]
- 10.1176/appi.ajp.164.2.290 · DOI
- 10.1002/da.20271 · DOI
- Sachdev P, 1995, J Nerv Ment Dis, 183, 408, 10.1097/00005053-199506000-00010 · doi:10.1097/00005053-199506000-00010
- 10.1345/aph.1C040 · doi:10.1345/aph.1c040 · Paper page
- Saxena S, 1996, J Clin Psychiatry, 57, 303
- Seedat S, 2004, J Clin Psychiatry, 65, 244
- Shader RI, 1993, New Engl J Med, 13, 1398
- Sharp DM, 1997, Br J Gen Pract, 47, 150
- Simon NM, 2003, Psychopharmacol Bull, 37, 66
- Simon NM, 2008, J Clin Psychiatry, e1
- Stein DJ, 1999, S Afr Med J, 89, 402
- 10.3109/10401230600948431 · doi:10.3109/10401230600948431
- Stein DJ, 2007, Eur Neuropsychophar17(Suppl, 4, S509, 10.1016/S0924-977X(07)70784-8 · doi:10.1016/s0924-977x(07)70784-8
- Strand M, 1990, J Clin Psychiatry (Suppl), 51, 40
- Telch MJ, 1995, J Consult Clin Psychol, 63, 823, 10.1037/0022-006X.63.5.823 · doi:10.1037/0022-006x.63.5.823
- Tesar GE, 1991, J Clin Psychiatry, 52, 69
- Tiffon L, 1994, J Clin Psychiatry, 55, 66
- Todorov C, 2000, Can J Psychiatry, 45, 257, 10.1177/070674370004500304 · doi:10.1177/070674370004500304
- Turner SM, 1994, J Consult Clin Psychol, 62, 350, 10.1037/0022-006X.62.2.350 · DOI · Paper page
- van Ameringen M, 1993, J Clin Psychiatry, 54, 27
- van der Kolk BA, 1994, J Clin Psychiatry, 55, 517
- Wetherell JL, 2003, J Consult Clin Psychol, 71, 31, 10.1037/0022-006X.71.1.31 · DOI · Paper page
- WHO, 1991, Clinical Descriptions and Diagnostic Guidelines
- Woodman CL, 1994, J Clin Psychiatry, 55, 134
- Worthington JJ, 1998, Psychopharmacol Bull, 34, 199
- Zitterl W, 1999, Wien Klin Wochenschr, 111, 439
- Zohar J, 2006, Obsessive-compulsive disorder and comorbidity, 79
Cited by
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079
Self-citationStein, D. J., Costa, D. L. C., Lochner, C., Miguel, E. C., Reddy, Y. C. J., Shavitt, R. G., van den Heuvel, O. A., & Simpson, H. B. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0102-3 · Cited by 895
Treatment of anxiety disorders
Bandelow, B., Michaelis, S., & Wedekind, D. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/bbandelow · Cited by 811
Self-citationObsessive-compulsive disorder: An integrative genetic and neurobiological perspective
Pauls, D. L., Abramovitch, A., Rauch, S. L., & Geller, D. A. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3746 · Cited by 793
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Self-citation
Metadata
- Authors
- Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., & WFSBP TASK FORCE ON TREATMENT GUIDE
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 9
- Issue
- 4
- Pages
- 248-312
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W1966065460
- Cited by
- 854
- References
- 826
- FWCI
- 73.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.